SHEMESH SHAY (Chief Development Officer) received a stock award from NUVECTIS PHARMA, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/5/2024ACC: 0001104659-24-001820
Officer· Chief Development Officer
Since Feb 2022
+130K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
130K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+130K
Price / share
—
Trade value
—
% of position
9.5%
1/3/2024
1.36M→1.49M
Total
Net shares
+130K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/3/2024 | A · Award | +130K | — | — | 9.5% | 1.36M | 1.49M |
| Total | +130K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported